{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T21:46:44Z","timestamp":1765057604728},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1093\/bmb\/ldx018","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T11:10:05Z","timestamp":1498561805000},"page":"79-89","source":"Crossref","is-referenced-by-count":7,"title":["Anticoagulation after coronary stenting: a systemic review"],"prefix":"10.1093","volume":"123","author":[{"given":"Zhe","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,7,1]]},"reference":[{"key":"key\n\t\t\t\t20170908050422_ldx018C1","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C3","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C4","first-page":"144","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization","volume":"68","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"key\n\t\t\t\t20170908050422_ldx018C5","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"American College of Emergency Physicians; Society for Cardiovascular Angiography and Interventions","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C6","article-title":"Is routine post-procedural anticoagulation warranted after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction? Insights from the HORIZONS-AMI trial","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20170908050422_ldx018C7","article-title":"Utility of post-procedural anticoagulation after primary PCI for STEMI: insights from a pooled analysis of the HORIZONS-AMI and EUROMAX trials","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"key\n\t\t\t\t20170908050422_ldx018C8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1160\/TH07-10-0644","article-title":"Bivalirudin","volume":"99","year":"2008","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170908050422_ldx018C9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1067\/mhj.2002.122173","article-title":"Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)","volume":"143","year":"2002","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.amjcard.2004.01.033","article-title":"Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)","volume":"93","year":"2004","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale","volume":"156","year":"2008","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1311096","article-title":"Bivalirudin started during emergency transport for primary PCI","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C13","article-title":"One-Year Mortality for Bivalirudin vs Heparins Plus Optional Glycoprotein IIb\/IIIa Inhibitor Treatment Started in the Ambulance for ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of the EUROMAX Randomized Clinical Trial","year":"2017","journal-title":"JAMA Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C14","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170908050422_ldx018C15","first-page":"414","article-title":"Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting","volume":"8","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t20170908050422_ldx018C16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2015.2323","article-title":"Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial","volume":"313","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170908050422_ldx018C17","article-title":"Effect of postprocedural full-does infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world population","year":"2017","journal-title":"Cardiovasc Ther"},{"key":"key\n\t\t\t\t20170908050422_ldx018C18","article-title":"Bivalirudin versus heparin in women undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2009.09.001","article-title":"Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST)","volume":"158","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170908050422_ldx018C21","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2015.02.050","article-title":"Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation: The ISAR-TRIPLE Trial","volume":"65","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C22","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/eurheartj\/eht049","article-title":"New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis","volume":"34","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t20170908050422_ldx018C24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijcard.2016.07.069","article-title":"Left ventricular thrombi after STEMI in the primary PCI era: a systematic review and meta-analysis","volume":"221","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C25","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s00059-015-4378-0","article-title":"Diagnosis and management of acute pulmonary embolism. ESC guidelines 2014","volume":"40","author":"European Society of Cardiology","year":"2015","journal-title":"Herz"},{"key":"key\n\t\t\t\t20170908050422_ldx018C27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170908050422_ldx018C28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ahj.2014.12.006","article-title":"An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI)","volume":"169","year":"2015","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170908050422_ldx018C29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/clc.22572","article-title":"Design and Rationale of the RE-DUAL PCI Trial: a prospective, randomized, Phase 3b study comparing the safety and efficacy of dual antithrombotic therapy with dabigatran etexilate versus warfarin triple therapy in patients with nonvalvular atrial fibrillation who have undergone percutaneous coronary intervention with stenting","volume":"39","year":"2016","journal-title":"Clin Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C30","first-page":"290","article-title":"Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation","volume":"12","year":"2016","journal-title":"Postepy Kardiol Interwencyjnej"},{"key":"key\n\t\t\t\t20170908050422_ldx018C31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"key":"key\n\t\t\t\t20170908050422_ldx018C32","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C34","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C35","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C36","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170908050422_ldx018C37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10557-016-6692-z","article-title":"Risk and benefits of triple therapy in patients undergoing coronary stent implantation requiring oral anticoagulation: a meta-analysis of 16 studies","volume":"30","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"key\n\t\t\t\t20170908050422_ldx018C38","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jacc.2010.09.010","article-title":"ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170908050422_ldx018C39","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a \u2018real world\u2019 nationwide cohort study","volume":"106","year":"2011","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20170908050422_ldx018C40","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","article-title":"Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial","volume":"127","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170908050422_ldx018C41","first-page":"888","article-title":"A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"38","year":"2017","journal-title":"Eur Heart J"}],"container-title":["British Medical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/bmb\/article-pdf\/123\/1\/79\/19719444\/ldx018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T05:53:52Z","timestamp":1569563632000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/bmb\/article\/123\/1\/79\/3903092\/Anticoagulation-after-coronary-stenting-a-systemic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,7,1]]},"published-print":{"date-parts":[[2017,9]]}},"URL":"https:\/\/doi.org\/10.1093\/bmb\/ldx018","relation":{},"ISSN":["0007-1420","1471-8391"],"issn-type":[{"value":"0007-1420","type":"print"},{"value":"1471-8391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,1]]}}}